NEVVI Medicare utilization intelligence
or

← back

Provider profile

ULMER, SCOTT M.D.

Hematology-Oncology · NPI 1063441772 · SAN ANTONIO, TX

1
Groups
59
Codes · 2024
62,522
Disclosed services

ULMER, SCOTT is a Hematology-Oncology in SAN ANTONIO, TX, a member of 1 medical group, who billed 59 distinct codes to Medicare Part B in 2024.

Groups: SOUTH TEXAS ONCOLOGY AND HEMATOLOGY, PLLC (SAN ANTONIO, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

62,522
disclosed services
59
codes billed to Medicare Part B
Prior year · CY2023 96,527 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J0897 Injection, denosumab, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J2405 Injection, ondansetron hydrochloride, per 1 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
83615 Lactate dehydrogenase (enzyme) level
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
83540 Iron level
83550 Iron binding capacity
82728 Ferritin (blood protein) level
J2469 Injection, palonosetron hcl, 25 mcg
96413 Administration of chemotherapy into vein, 1 hour or less
82784 Gammaglobulin (immune system protein) measurement
83735 Magnesium level
96372 Injection of drug or substance under skin or into muscle
96375 Injection of additional new drug or substance into vein
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
J1200 Injection, diphenhydramine hcl, up to 50 mg
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J3490 Unclassified drugs
82378 Carcinoembryonic antigen (cea) protein level
J7030 Infusion, normal saline solution , 1000 cc
96361 Infusion into a vein for hydration, each additional hour
84100 Phosphate level
96417 Administration of additional new drug or substance into vein, 1 hour or less
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96415 Administration of chemotherapy into vein, each additional hour
84550 Uric acid level, blood
85610 Blood test, clotting time
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96360 Infusion into a vein for hydration, 31-60 minutes
80048 Blood test, basic group of blood chemicals (calcium, total)
84153 Psa (prostate specific antigen) measurement, total
82607 Cyanocobalamin (vitamin b-12) level
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg
99195 Drawing of blood for a medical problem
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
96523 Irrigation of implanted venous access drug delivery device
86706 Hepatitis b surface antibody measurement
87340 Detection test by immunoassay technique for hepatitis b surface antigen
86704 Hepatitis b core antibody measurement
86803 Hepatitis c antibody measurement
85045 Red blood count, automated test
85730 Coagulation assessment blood test, plasma or whole blood
84439 Thyroxine (thyroid chemical), free
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg
87389 Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.